Clinical Trial Update: The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease

View source ↗

Summary

This clinical trial update examines how 6-MP metabolite levels affect infliximab pharmacokinetics and the development of anti-infliximab antibodies in Crohn's d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease

Drugs mentioned

• 6-mercaptopurine (6-mercaptopurine)
• Infliximab (infliximab)

Snippet

Sponsor: Ernest Seidman | Conditions: Inflammatory Bowel Disease, Crohn's Disease | Status: UNKNOWN